SG/CALL/STRYKER CORP./440/0.1/20.09.24 Stock

Warrant

DE000SW7ENZ8

Real-time Bid/Ask 06:12:03 2024-06-04 EDT
0.01 EUR / 0.12 EUR +828.57% Intraday chart for SG/CALL/STRYKER CORP./440/0.1/20.09.24
Current month-86.27%
1 month-58.82%
Date Price Change
24-06-04 0.066 +842.86%
24-06-03 0.007 -86.27%
24-05-31 0.051 -31.08%
24-05-30 0.074 +7,300.00%
24-05-29 0.001 0.00%

Delayed Quote Börse Stuttgart

Last update June 04, 2024 at 04:21 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SW7ENZ
ISINDE000SW7ENZ8
Date issued 2024-03-07
Strike 440 $
Maturity 2024-09-20 (109 Days)
Parity 10 : 1
Emission price 0.47
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.47
Lowest since issue 0.001
Spread 0.11
Spread %91.67%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
339.4 USD
Average target price
373.1 USD
Spread / Average Target
+9.92%
Consensus